Results 71 to 80 of about 2,408 (176)

Inhibition of hepatic microsomal triglyceride transfer protein – a novel therapeutic option for treatment of homozygous familial hypercholesterolemia

Vascular Health and Risk Management, 2014
Alpo Vuorio,1,2 Matti J Tikkanen,3 Petri T Kovanen4 1Health Center Mehiläinen, Vantaa, Finland; 2Finnish Institute of Occupational Health, Lappeenranta, Finland; 3Heart and Lung Center, Helsinki University Central Hospital, Folkhälsan Research ...
Vuorio A, Tikkanen MJ, Kovanen PT
doaj  

Discontinuation of LDL apheresis with evolocumab in an FH patient with a duplication of exon 2-6 in the LDLR gene. [PDF]

J Cardiol Cases, 2019
Nose D, Hori M, Miyamoto Y, Imaizumi S, Harada-Shiba M, Saku K, Miura SI.   +6 more
europepmc   +1 more source

Lipoprotein apheresis in the management of severe hypercholesterolemia and of elevation of lipoprotein(a): current perspectives and patient selection

Medical Devices: Evidence and Research, 2016
Ulrich Julius Lipidology and Center for Extracorporeal Therapy, Department for Internal Medicine III, University Hospital Carl Gustav Carus at the Technische Universität Dresden, Dresden, Germany Abstract: This review reports the current situation ...
Julius U
doaj  

Impact of selective LDL apheresis on serum chemerin levels in patients with hypercholesterolemia. [PDF]

Lipids Health Dis, 2016
Varga VE, Lőrincz H, Zsíros N, Fülöp P, Seres I, Paragh G, Balla J, Harangi M.   +7 more
europepmc   +1 more source

LDL-apheresis.

Jinko Zoki, 1986
YOKOYAMA, S., YAMAMOTO, A., HAYASHI, R., SATANI, M.   +3 more
openaire   +1 more source

Marked Clinical Improvement in Parkinson's Disease Following Double-Filtration Apheresis: A Case Report. [PDF]

Degener Neurol Neuromuscul Dis
Burgard H.
europepmc   +1 more source

Clinical and genetic characterization of homozygous <i>LDLR</i> variants in familial hypercholesterolaemia: insights from two case reports. [PDF]

Eur Heart J Case Rep
Sahoo SK, Singh PK, Barik R, Prakash S, Sahoo D, Mohanty CR, Malla SR, Mohapatra RK.   +7 more
europepmc   +1 more source

Treatment-resistant PLA2R-negative membranous nephropathy responsive to low-density lipoprotein apheresis. [PDF]

J Clin Apher, 2019
Szymanski JM, Waldman M, Conry-Cantilena C, West KA.   +3 more
europepmc   +1 more source

Managing Progressive Atherosclerotic Cardiovascular Disease in a Patient with Elevated Lipoprotein(a). [PDF]

Anatol J Cardiol
Yurtseven E, Tokgözoğlu L.
europepmc   +1 more source

Efficacy of Low-Density Lipoprotein Apheresis in an Adult Case of Recurrent Focal Segmental Glomerulosclerosis Post-kidney Transplant. [PDF]

Cureus
Javanbakht A, Souter K, Armendariz T, Webb CB.   +3 more
europepmc   +1 more source